Departments of Radiation Oncology and; Pediatrics, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, New York.
Department of Radiation Oncology and Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Int J Radiat Oncol Biol Phys. 2024 Jun 1;119(2):321-337. doi: 10.1016/j.ijrobp.2023.09.005. Epub 2023 Nov 23.
Pediatric Normal Tissue Effects in the Clinic (PENTEC) is an international multidisciplinary effort that aims to summarize normal-tissue toxicity risks based on published dose-volume data from studies of children and adolescents treated with radiation therapy (RT) for cancer. With recognition that children are uniquely vulnerable to treatment-related toxic effects, our mission and challenge was to assemble our group of physicians (radiation and pediatric oncologists, subspecialists), physicists with clinical and modeling expertise, epidemiologists, and other scientists to develop evidence-based radiation dosimetric guidelines, as affected by developmental status and other factors (eg, other cancer therapies and host factors). These quantitative toxicity risk estimates could serve to inform RT planning and thereby improve outcomes. Tandem goals included the description of relevant medical physics issues specific to pediatric RT and the proposal of dose-volume outcome reporting standards to inform future studies. We created 19 organ-specific task forces and methodology to unravel the wealth of data from heterogeneous published studies. This report provides a high-level summary of PENTEC's genesis, methods, key findings, and associated concepts that affected our work and an explanation of how our findings may be interpreted and applied in the clinic. We acknowledge our predecessors in these efforts, and we pay homage to the children whose lives informed us and to future generations who we hope will benefit from this additional step in our path forward.
儿科正常组织器官临床效应(PENTEC)是一项国际性多学科的努力,旨在根据儿童和青少年癌症放射治疗(RT)研究中发表的剂量-体积数据,总结正常组织毒性风险。认识到儿童对治疗相关毒性效应特别敏感,我们的使命和挑战是召集我们的医生(放射肿瘤学家和儿科肿瘤学家、亚专科医生)、具有临床和建模专业知识的物理学家、流行病学家和其他科学家,制定基于证据的放射剂量学指南,这些指南受到发育状态和其他因素的影响(例如,其他癌症治疗和宿主因素)。这些定量毒性风险估计可用于指导 RT 计划,从而改善治疗效果。我们还确立了相关的医学物理问题的描述,以及针对儿科 RT 的剂量-体积结果报告标准,以指导未来的研究。我们创建了 19 个特定于器官的工作组和方法,以梳理来自异质发表研究的大量数据。本报告概述了 PENTEC 的起源、方法、主要发现以及影响我们工作的相关概念,并解释了我们的发现如何在临床中得到解释和应用。我们感谢在这些努力中的前辈,向那些为我们提供信息的儿童以及我们希望从中受益的未来几代人表示敬意。